A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927

NCT00800215 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: iv SPM 927 and oral placebo tablet
DRUG: oral SPM 927 tablet and iv placebo
DRUG: iv SPM 927 and oral placebo tablet
DRUG: oral SPM 927 tablet and iv placebo

Sponsor

UCB Pharma